Aventis S.A.

TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care than National Average.
Heart Disease Weekly; 11/22/2009; 1423 words; ...of helping Texas employers play an active and enthusiastic role in promoting cost-effective delivery of quality health care to the benefit of the community. The report was produced with assistance from sanofi-aventis U.S. About the Dall

Sanofi Pasteur Presents Safety Data on Menactra Vaccine Given to Infants at Infectious Disease Society Meeting.
Pediatrics Week; 11/21/2009; 867 words; ...Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY...Miriam Pina, M.D., Sanofi Pasteur's clinical director who presented the data...Pharmaceutical Company, Sanofi Pasteur, Sanofi-Aventis, Vaccines. This article was prepared...

CHI Gathers Biomedical Community for the California Healthcare Policy Forum.
Blood Weekly; 11/19/2009; 982 words; ...biotechnology. California's biomedical community is made...tomorrow," said Martin, CHI's chairman. CHI thanks its sponsors...Sciences, Gold sponsors: Sanofi-Aventis and Genentech, Silver sponsor...research organizations. CHI's mission is to advance responsible...

NovaDel Receives Notice of Allowance for New U.S. Patent Covering its Oral Spray Drug Delivery Technology.
Biotech Week; 11/18/2009; 1307 words; ...granted nine patents in the U.S., three patents in Canada and...prepared to get a full night's sleep (7-8 hours). Patients...registered trademark of sanofi-aventis. ABOUT NOVADEL PHARMA NovaDel...marketed drugs. The Company's proprietary technology offers...

CombinatoRx Reports Financial Results for the Third Quarter 2009.(Financial report)
Biotech Week; 11/18/2009; 1615 words; ...REMS program, Sanofi-Aventis' acquisition of Prednisporin...revenue, and Neuromed's proven drug development...marketing approval by the U.S. Food and Drug Administration...23, 2009, the FDA's Anesthetics and Life Support...key asset by Sanofi-Aventis in its pending acquisition...